326 related articles for article (PubMed ID: 33216939)
21. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.
Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LT; Kristensen LE; Feltelius N; Hetland ML; Askling J;
Ann Rheum Dis; 2017 Jan; 76(1):105-111. PubMed ID: 27147709
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic delay is associated with uveitis and inflammatory bowel disease in AS: a study of extra-musculoskeletal manifestations in SpA.
Michelena X; Zhao SS; Marco-Pascual C; Almirall M; Collantes-Estevez E; Font-Ugalde P; López-Medina C; Wei JC; Morgan AW; Rodríguez J; Juanola X; Vázquez-Mellado J; Marzo-Ortega H
Rheumatology (Oxford); 2024 Feb; 63(2):430-435. PubMed ID: 37184889
[TBL] [Abstract][Full Text] [Related]
23. The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
Lie E; Kristensen LE; Forsblad-d'Elia H; Zverkova-Sandström T; Askling J; Jacobsson LT;
Ann Rheum Dis; 2015 Jun; 74(6):970-8. PubMed ID: 25710471
[TBL] [Abstract][Full Text] [Related]
24. One year in review 2018: axial spondyloarthritis.
Carli L; Calabresi E; Governato G; Braun J
Clin Exp Rheumatol; 2019; 37(6):889-898. PubMed ID: 31796161
[TBL] [Abstract][Full Text] [Related]
25. Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors.
Emond B; Ellis LA; Chakravarty SD; Ladouceur M; Lefebvre P
Curr Med Res Opin; 2019 Oct; 35(10):1751-1759. PubMed ID: 31106607
[No Abstract] [Full Text] [Related]
26. Is family history a predictor of response to tumour necrosis factor inhibitors in spondyloarthritis? A Swedish nationwide cohort study.
Morin M; Hellgren K; Lindström U; Frisell T
Scand J Rheumatol; 2022 Jan; 51(1):10-20. PubMed ID: 33755519
[No Abstract] [Full Text] [Related]
27. Uveitis-related Factors in Patients With Spondyloarthritis: TReasure Real-Life Results.
Yaşar Bilge NŞ; Kalyoncu U; Atagündüz P; Dalkılıç E; Pehlivan Y; Küçükşahin O; Bes C; Akar S; Cinar M; Emmungil H; Ersözlü D; Ateş A; Mercan R; Kimyon G; Koca SS; Gonullu E; Yazisiz V; Tekgöz E; Alpay-Kanitez N; Erden A; Kiraz S; Coskun BN; Yağız B; İlgen U; Karadağ Ö; Kilic L; Ertenli İ; Kasifoglu T
Am J Ophthalmol; 2021 Aug; 228():58-64. PubMed ID: 33826929
[TBL] [Abstract][Full Text] [Related]
28. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?
Mitulescu TC; Trandafir M; Dimăncescu MG; Ciuluvică RC; Popescu V; Predețeanu D; Istrate S; Voinea LM
Rom J Ophthalmol; 2018; 62(2):114-122. PubMed ID: 30206554
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis.
Pittam B; Gupta S; Harrison NL; Robertson S; Hughes DM; Zhao SS
Rheumatology (Oxford); 2020 Sep; 59(9):2199-2206. PubMed ID: 32160297
[TBL] [Abstract][Full Text] [Related]
30. Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study.
Stolwijk C; Essers I; van den Bosch F; Dougados M; Etcheto A; van der Heijde D; Landewé R; Molto A; van Tubergen A; Boonen A;
Rheumatology (Oxford); 2020 Jul; 59(7):1632-1639. PubMed ID: 31665462
[TBL] [Abstract][Full Text] [Related]
31. Comorbidities in patients with spondyloarthritis.
van der Horst-Bruinsma IE; Nurmohamed MT; Landewé RB
Rheum Dis Clin North Am; 2012 Aug; 38(3):523-38. PubMed ID: 23083753
[TBL] [Abstract][Full Text] [Related]
32. Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden.
Hellgren K; Smedby KE; Backlin C; Sundstrom C; Feltelius N; Eriksson JK; Baecklund E; Askling J
Arthritis Rheumatol; 2014 May; 66(5):1282-90. PubMed ID: 24782185
[TBL] [Abstract][Full Text] [Related]
33. Extra-Articular Manifestations in Patients with Ankylosing Spondylitis: Baseline Characteristics from the RBSMR Study.
Ouardi NE; Djossou JH; Taoubane L; Ghassem MA; Toufik H; Majjad A; Sadni S; Hmamouchi I; Abouqal R; Bahiri R; Allali F; Bouchti IE; Ghozlani I; Hassikou H; Harzy T; Ichchou L; Mkinsi O; Niamane R; Maghraoui AE; Achemlal L
Mediterr J Rheumatol; 2022 Sep; 33(3):316-321. PubMed ID: 36531422
[TBL] [Abstract][Full Text] [Related]
34. Uveitis in Spondyloarthritis: An Overview.
Cantini F; Nannini C; Cassarà E; Kaloudi O; Niccoli L
J Rheumatol Suppl; 2015 Nov; 93():27-9. PubMed ID: 26523051
[TBL] [Abstract][Full Text] [Related]
35. Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study.
de Vries MK; Arkema EV; Jonsson J; Bruchfeld J; Jacobsson LTH; Askling J;
Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1563-1567. PubMed ID: 29195024
[TBL] [Abstract][Full Text] [Related]
36. Axial spondyloarthritis: thoughts about nomenclature and treatment targets.
Braun J
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S132-5. PubMed ID: 23079005
[TBL] [Abstract][Full Text] [Related]
37. First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early).
Rojas-Vargas M; Muñoz-Gomariz E; Escudero A; Font P; Zarco P; Almodovar R; Gratacós J; Mulero J; Juanola X; Montilla C; Moreno E; Collantes-Estevez E;
Rheumatology (Oxford); 2009 Apr; 48(4):404-9. PubMed ID: 19208685
[TBL] [Abstract][Full Text] [Related]
38. Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
Card TR; Langan SM; Chu TP
Dig Dis Sci; 2016 Sep; 61(9):2619-26. PubMed ID: 27193564
[TBL] [Abstract][Full Text] [Related]
39. Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study.
Charlton R; Green A; Shaddick G; Snowball J; Nightingale A; Tillett W; Smith CH; McHugh N;
Ann Rheum Dis; 2018 Feb; 77(2):277-280. PubMed ID: 29092855
[TBL] [Abstract][Full Text] [Related]
40. Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials.
Schreiber S; Colombel JF; Feagan BG; Reich K; Deodhar AA; McInnes IB; Porter B; Das Gupta A; Pricop L; Fox T
Ann Rheum Dis; 2019 Apr; 78(4):473-479. PubMed ID: 30674475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
